Top Markets
#1 Palladium Network Palladium Network +27.89%
#2 Ankr Network Ankr Network +10.42%
#3 would would +6.86%
#4 Hive Hive +6.25%
#5 WAX WAX +5.69%
#6 Pons Pons +4.94%
#7 The Bitcoin Bull The Bitcoin Bull +4.43%
#8 OpenAI (Republic Pre-IPO) OpenAI (Republic Pre-IPO) +4.16%
#9 edgeX edgeX +3.72%
#10 Ribbita by Virtuals Ribbita by Virtuals +3.31%
Coin of the day
Palladium Network Palladium Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Rangering i aksjer #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Aksjekurs
$5.84
Sist synkronisert: 2025-04-02
Markedsverdi
$224.09M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Nevro Corp. (NVRO)

Kategori

Healthcare
P/S-forhold for Nevro Corp. (NVRO)
P/S-forhold per September 2026 TTM: 0.55
Ifølge Nevro Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0.55. Ved slutten av 2023 hadde selskapet et P/S-forhold på 1.82.
P/S-historikk for Nevro Corp. fra 2012 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 0.55 61.32%
2024 0.34 -81.46%
2023 1.82 -47.08%
2022 3.44 -52.83%
2021 7.30 -54.68%
2020 16.10 73.55%
2019 9.28 207.44%
2018 3.02 -51.47%
2017 6.22 -31.35%
2016 9.06 -64.87%
2015 25.78 389.03%
2014 5.27 623.47%
2013 0.73 -22.76%
2012 0.94 0.00%
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.10 647.29%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.80 775.92%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 407.73%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.42 523.39%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.02 1,362.88%
US